Skip to content

CG Oncology

US · CGON #1929 by market cap Listed 2024
62.38 -1.26 -1.98%
Live - 5344 symbols - heartbeat 31s ago · 2026-10-08 04:49
Pre-market 61.56 -1.31%
After-hours 62.38 0.00%
Market cap
5.53B
P/B
5.37
EPS
-2.08
Reader sentiment Are you bullish or bearish on CGON?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.9 percentage points.

Institutional ownership

Held by institutions
116.10% -1.93pp
Institutions
299 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund62.34%
VC/PE Fund26.79%
Hedge Fund18.81%
Public Company4.46%
Private Company3.21%
Individual/Insider0.92%
Government Pension Fund0.27%
Insurance Company0.21%

Top holders as of 2026-06-30

T. Rowe Price Group, Inc. 11.76% · 10.42M sh
RTW Investments, LP 9.61% · 8.51M sh
Decheng Capital LLC 7.19% · 6.37M sh
BlackRock 7.06% · 6.26M sh
Wellington Management Group 6.01% · 5.32M sh
Longitude Capital Management Co., LLC 5.26% · 4.66M sh
FMR 4.69% · 4.16M sh
Vanguard Capital Management, LLC 4.35% · 3.86M sh
TCG Crossover Management, LLC 4.14% · 3.67M sh
ORI Capital 3.94% · 3.49M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 14 buys · 36 sells

NameRoleStake
Hong Fang Song Independent Director 0.69%
Arthur Kuan Chairperson & CEO 0.22%
Corleen Roche Chief Financial Officer 0.00%
Vijay Kasturi Chief Medical Officer 0.00%
Leonard Post Lead Independent Director --
James DeTore Interim Principal Financial & Accounting Officer --
Victor Tong Independent Director --
Ambaw Bellete President --
Susan Graf Independent Director --
ORI Capital -- --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-20 Ambaw Bellete President Intent to Sell (Form 144) -30,787 $76.01
2026-09-16 Ambaw Bellete President Intent to Sell (Form 144) -6,532 $76.50
2026-09-14 Leonard Post Lead Independent Director Derivative Exercise and Sale -1,000 $0.60–72.98
2026-09-10 Ambaw Bellete President Intent to Sell (Form 144) -826 $75.00
2026-09-01 Ambaw Bellete President Intent to Sell (Form 144) -29,630 $77.61
2026-08-30 Ambaw Bellete President Intent to Sell (Form 144) -50,000 $75.51
2026-08-26 Ambaw Bellete President Intent to Sell (Form 144) -5,789 $79.39
2026-08-24 Ambaw Bellete President Intent to Sell (Form 144) -10,551 $79.55
2026-08-23 Ambaw Bellete President Intent to Sell (Form 144) -5,762 $79.52
2026-08-18 Ambaw Bellete President Intent to Sell (Form 144) -100,000 $79.54
2026-08-16 Ambaw Bellete President Intent to Sell (Form 144) -52,438 $76.95
2026-08-13 Leonard Post Lead Independent Director Derivative Exercise and Sale -1,000 $0.60–74.54
2026-08-13 Ambaw Bellete President Intent to Sell (Form 144) -19,364 $75.02
2026-08-12 Ambaw Bellete President Intent to Sell (Form 144) -25,989 $75.95
2026-08-11 Ambaw Bellete President Intent to Sell (Form 144) -32,137 $78.62
2026-08-10 Ambaw Bellete President Intent to Sell (Form 144) -50,000 $76.21
2026-08-09 Ambaw Bellete President Intent to Sell (Form 144) -50,000 $75.41
2026-08-06 Ambaw Bellete President Intent to Sell (Form 144) -9,250 $75.25
2026-08-05 Ambaw Bellete President Intent to Sell (Form 144) -75,000 $75.63
2026-08-04 Ambaw Bellete President Intent to Sell (Form 144) -25,000 $73.50

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 04:49:36 · For reference only, not investment advice and not tailored to your situation.